Search

everythinglearnresearchcommunity

for

Search:↓

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The patient has frontal fibrosing alopecia (FFA).

Frontal fibrosing alopecia can occur in children, not just postmenopausal women.

Lichen planus pigmentosus and fibrosing frontal alopecia in Colombia are likely different stages of the same disease.

Body-hair transplant successfully improved scarred areas and frontal hair density without visible chest scarring.

Some people with lichen planus pigmentosus might later develop frontal fibrosing alopecia.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

Hair restoration should include the parietal eminence area for better balance in frontal and lateral profiles and to improve the head's contours.

Lichen planopilaris (LPP) is linked to androgen excess, while frontal fibrosing alopecia (FFA) is linked to androgen deficiency.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

AGA more common in men, Koreans have lower rates and unique patterns.

Hair loss increases with age; alcohol raises risk, more female partners lowers it.

Androgenetic alopecia in women needs more research and better management strategies.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

Trichoscopy can diagnose female hair loss with high accuracy by looking for specific patterns in hair and scalp appearance.

The BASP classification is a detailed and accurate way to categorize hair loss in both men and women.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

The unit area trichogram is a reliable method to assess hair loss and treatment response in people with androgenic alopecia by measuring hair density and thickness.

Dermoscopy helps diagnose and monitor treatment for hair loss from scarring conditions like discoid lupus and lichen planopilaris.

Some women with common hair loss may develop permanent hair loss.

Trichoscopy is a quick, cost-effective tool for diagnosing different hair loss conditions.

Tight hairstyles and chemical relaxers can cause hair loss known as traction alopecia.

Small white dots on the scalp seen with a dermoscope correspond to sweat ducts and vary with different hair disorders.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Creating a natural-looking hairline in hair restoration surgery involves using follicular unit grafts, proper hair placement, and artistic skills to give the illusion of density.

The updated SALT II tool offers a more precise way to measure scalp hair loss.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.